Q Fever News and Research

RSS

Closing bars and restaurants does not appear to have suppressed COVID-19 in Japan

In a recent study posted in the Research Square* preprint server, which is under consideration at the journal Scientific Reports, a team of researchers conducted a longitudinal survey in 11 Japanese prefectures to evaluate whether early closure of full-service restaurants and bars reduced the incidence and symptoms of coronavirus disease 2019 (COVID-19) during February 2021.

23 Feb 2022

Gene therapy leads to durable transfusion independence in youngest patients with thalassemia

Over 90 percent of patients with transfusion-dependent thalassemia, an inherited blood disorder, no longer needed monthly blood transfusions years after receiving gene therapy, according to an international Phase 3 clinical trial that for the first time included children younger than 12 years of age.

22 Feb 2022

CD91 receptor promotes SARS-CoV-2 infection

researchers find that LRP1/CD91 is a leading molecule in virus-host cell interactions that causes infection by many RNA viruses.

22 Feb 2022

Prevalence of chemosensory loss induced by SARS-CoV-2 Omicron variant in Italy

Researchers conducted a prospective cohort study to determine the prevalence of chemosensory dysfunction in mild to moderate COVID-19 patients in Italy.

22 Feb 2022

SARS-CoV-2 occurrence compared with other respiratory viruses in children with acute respiratory infections

The current study examined the incidence of COVID-19 in children with ARI relative to other respiratory viruses during the second and third waves.

22 Feb 2022

Climate change is sickening, literally!

A news study highlights the change in disease spread with climate change across the globe.

21 Feb 2022

The effect of COVID-19 vaccination on long COVID symptoms

Researchers assessed the effectiveness of COVID-19 vaccines in patients experiencing long COVID.

21 Feb 2022

Immunogenicity, efficacy, and safety of BNT162b2 or mRNA1273 fourth dose

A recent study explored the safety, immunogenicity, and VE of the SARS-CoV-2 mRNA BNT162b2 and mRNA1273 vaccines against its Omicron VOC in HCWs in Israel.

18 Feb 2022

COVID test-to-return may help shorten time away from school

In a recent study posted to the medRxiv* preprint server, a test-to-return approach for students in isolation is explored for its utility in sorting out students who can safely return to school without jeopardizing others, from those with a high viral load.

17 Feb 2022

Certain flavonoids inhibit an enzyme involved in the formation of key hormone in yellow fever mosquito

When most people think of flavonoids, natural compounds found in plants and other organisms, their nutritional benefits probably come to mind first.

17 Feb 2022

Trial of early antiviral therapy for COVID-19 shows no significant benefit

A new preprint research paper examines the efficacy of using three antivirals in various combinations in early infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

17 Feb 2022

Frequency and function of SARS-CoV-2-specific T cells in individuals with pulmonary PASC

Researchers examined patients with pulmonary PASC of SARS-CoV-2 to determine the frequency and function of SARS-CoV-2-specific T cells in their blood.

17 Feb 2022

Study determines 115 long COVID symptoms and their associated risk factors

A new study determined which symptoms are linked with confirmed SARS-CoV-2 infection beyond 12 weeks post-infection in non-hospitalized individuals, and investigated the associated risk-factors of such symptoms.

17 Feb 2022

First cases of co-infection with Delta and Omicron identified during local co-circulation of both SARS-CoV-2 lineages

Researchers revealed the co-infection of the SARS-CoV-2 Delta and Omicron variants in two epidemiologically unrelated patients suffering from chronic kidney disease and requiring hemodialysis

17 Feb 2022

Risk factors for COVID-19 in older adult patients with cancer

Researchers develop a geriatric risk score to predict the risk of severe clinical outcomes in older cancer patients with COVID-19.

16 Feb 2022

UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19

The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications.

16 Feb 2022

Study confirms that pets can harbor SARS-CoV-2 infection

A new study looks at how dogs and cats within households are susceptible to COVID-19 infection from humans, and whether they act as reservoir species.

16 Feb 2022

Pregnancy outcomes of pregnant women infected by SARS-CoV-2

A new study evaluated the pregnancy outcomes of pregnant women in the third trimester who were infected by SARS-CoV-2 for the detection of the virus in the placenta and different samples of the newborn as well as detection of antibodies in the cord blood.

16 Feb 2022

UK's fight against zoonotic diseases receives a £200 million boost

The UK's fight against zoonotic diseases, including avian flu and bovine tuberculosis received a major boost today (16 February) with the allocation of £200 million for a programme of investment into world leading research facilities.

15 Feb 2022

£10 million of UK aid funding to support vaccine research for tackling world's deadliest diseases

Research into vaccines to tackle some of the world's deadliest diseases in low and middle income countries has been backed by £10 million of UK aid funding, the government has announced today (Wednesday 16 February).

15 Feb 2022

Q Fever News and Research

Closing bars and restaurants does not appear to have suppressed COVID-19 in Japan

Gene therapy leads to durable transfusion independence in youngest patients with thalassemia

CD91 receptor promotes SARS-CoV-2 infection

Prevalence of chemosensory loss induced by SARS-CoV-2 Omicron variant in Italy

SARS-CoV-2 occurrence compared with other respiratory viruses in children with acute respiratory infections

Climate change is sickening, literally!

The effect of COVID-19 vaccination on long COVID symptoms

Immunogenicity, efficacy, and safety of BNT162b2 or mRNA1273 fourth dose

COVID test-to-return may help shorten time away from school

Certain flavonoids inhibit an enzyme involved in the formation of key hormone in yellow fever mosquito

Trial of early antiviral therapy for COVID-19 shows no significant benefit

Frequency and function of SARS-CoV-2-specific T cells in individuals with pulmonary PASC

Study determines 115 long COVID symptoms and their associated risk factors

First cases of co-infection with Delta and Omicron identified during local co-circulation of both SARS-CoV-2 lineages

Risk factors for COVID-19 in older adult patients with cancer

UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19

Study confirms that pets can harbor SARS-CoV-2 infection

Pregnancy outcomes of pregnant women infected by SARS-CoV-2

UK's fight against zoonotic diseases receives a £200 million boost

£10 million of UK aid funding to support vaccine research for tackling world's deadliest diseases

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News